Inhibition of topoisomerase I function by coralyne and 5,6-dihydrocoralyne

Chemical Research in Toxicology

Volumn 9, Issue 1, 1996, Pages 75-83

  Wang, Li Kai ^a   Rogers, Brian D ^a   Hecht, Sidney M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DIHYDROCORALYNE; CAMPTOTHECIN; CORALYNE; DNA TOPOISOMERASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DNA CLEAVAGE; DNA STRAND BREAKAGE; DNA SUPERCOILING; ENZYME INHIBITION; TEMPERATURE;

BASE SEQUENCE; BERBERINE ALKALOIDS; DNA DAMAGE; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DRUG STABILITY; MOLECULAR SEQUENCE DATA;

EID: 0030054013     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx950080y     Document Type: Article

References (70)

1. Gellert, M (1981) DNA topoisomerases. Annu. Rev. Biochem. 50, 879-910.
2. Gupta, M., Fujimori, A., and Pommier, Y. (1995) Eukaryotic DNA topoisomerases I. Biochim. Biophys. Acta 1262, 1-14.
3. Wang, J. C. (1987) Recent studies of DNA topoisomerases. Biochim. Biophys. Acta 909, 1-9.
4. Wang, J. C. (1987) DNA topoisomerases: nature's solution to the topological ramifications of the double-helix structure of DNA. Harvey Lect. 81, 93-110.
5. Ralph, R. K., Judd, W., Pommier, Y., and Kohn, K. W. (1994) DNA N-alkylating agent - DNA interaction. In Topics in Molecular and Structural Biology, Molecular Aspects of Anticancer Drug - DNA Interactions (Neidle, S., and Waring, M., Eds.) Vol. 2, pp 1-95, Macmillan Press, London.
6. Champoux, J. J. (1977) Strand breakage by the DNA untwisting enzyme results in covalent attachment of the enzyme to DNA. Proc. Natl. Acad. Sci. U.S.A. 74, 3800-3804.
7. Liu, L. F., Rowe, T. C., Yang, L., Tewey, K. M., and Chen, G. L. (1983) Cleavage of DNA by mammalian DNA topoisomerase II. J. Biol. Chem. 258, 15365-15370.
8. Schneider, E., Hsiang, Y.-H., and Liu, L. F. (1990) DNA topoisomerases as anticancer drug targets. Adv. Pharmacol. 21, 149-183.
9. Liu, L. F. (1989) DNA topoisomerase poisons as antitumor drugs. Annu. Rev Biochem. 58, 351-375.
10. D'Arpa, P., and Liu, L. F. (1989) Topoisomerase-targeting anti-tumor drugs. Biochim. Biophys. Acta 989, 163-177.
11. Hsiang, Y.-H., Hertzberg, R. P., Hecht, S., and Liu, L. F. (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260, 14873-14878.
12. Andoh, T., Ishii, K., Suzuki, Y., Ikegami, Y., Kusunoki, Y., Takemoto, Y., and Okada, K. (1987) Characterization of a mammalian mutant with a camptothecin-resistam DNA topoisomerase I. Proc. Natl. Acad. Sci. U.S.A. 84, 5565-5569.
13. Gupta, R. S., Gupta, R., Eng, B., Lock, R. B., Ross, W. E., Hertzberg, R. P., Caranfa, M. J., and Johnson, R. K. (1988) Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I. Cancer Res. 48, 6404-6410.
14. Hertzberg, R. P., Caranfa, M. J., and Hecht, S. M. (1989) On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme - DNA complex. Biochemistry 28, 4629-4638.
15. Ross, W. E. (1985) DNA topoisomerases as targets for cancer therapy. Biochem. Pharmacol. 34, 4191-4195.
16. Hertzberg, R. P , Caranfa, M. J , Kingsbury, W. D., Smith, B., Johnson, R. K., and Hecht, S. M. (1991) The biochemistry of camptothecin - topoisomerase I interaction. In DNA Topoisomerases in Cancer (Potmesil, M., and Kohn, K. W., Eds.) pp 103-120, Oxford University Press, New York.
17. Hecht, S. M., Berry, D. E., MacKenzie, L. J., Busby, R. W., and Nasuti, C. A (1992) A strategy for identifying novel, mechanistically unique inhibitors of topoisomerase I. J. Nat. Prod. 55, 401-413.
18. Wang, L.K., Johnson, R. K., and Hecht, S. M. (1993) Inhibition of topoisomerase I function by nitidine and fagaronine. Chem. Res Toxicol. 6, 813-818.
19. Zee-Cheng, K.-Y., Paull, K. D , and Cheng, C. C. (1974) Experimental antileukemic agents. Coralyne, analogs, and related compounds. J. Med. Chem. 17, 347-351.
20. Zee-Cheng, R. K-Y., and Cheng, C. C. (1976) Tetramethoxydiben-zoquinolizinium salts. Preparation and antileukemic activity of some positional and structural isomers of coralyne J. Med. Chem 19, 882-886.
21. Wilson, W. D., Gough, A. N., Doyle, J. J., and Davidson, M. N. (1976) Coralyne. Intercalation with DNA as a possible mechanism of antileukemic action. J. Med. Chem. 19, 1261-1263.
22. Liu, L. F., and Davis, J. L. (1981) Novel topologically knotted DNA from bacteriophage P4 capsids: studies with DNA topoisomerases. Nucleic Acids Res. 9, 3979-3989.
23. Liu, L. F., and Miller, K. G. (1981) Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei. Proc. Natl. Acad. Sci. U.S.A. 78, 3487-3491.
24. Schon, E., Evans, T., Welsh, J., and Efstraiadis, A. (1983) Conformation of promoter DNA: fine mapping of S1-hypersensitive sites. Cell 35, 837-848.
25. Eckert, R. L. (1995) in Current Protocols in Molecular Biology (Albright, L. M., Coen, D. M., and Varki, A., Eds.) pp 7.5.1-7.5.11, John Wiley & Sons, New York.
26. Weimar, C., Angerer, S. V., and Wiegrebe, W. (1991) Methoxyand acetoxy-8-oxoberbines - synthesis, antitumor activity, and interaction with DNA. Arch. Pharm. (Weinheim, Ger.) 324, 509-518.
27. Mattern, M. R., Mong, S.-M., Bartus, H. F., Mirabelli, C. K., Crooke, S. T., and Johnson, R. K., (1987) Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Cancer Res. 47, 1793-1798.
28. Hsiang, Y -H., and Liu, L. F. (1988) Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 48, 1722-1726.
29. Thomsen, B., Mollerup, S , Bonven, B. J., Frank, R., Blocker, H., Nielsen, O. F., and Westergaard, O. (1987) Sequence specificity of DNA topoisomerase I in the presence and absence of camptothecin. EMBO J. 6, 1817-1823.
30. Kjeldsen, E., Mollerup, S., Thomsen, B., Bonven, B., Bolund, L., and Westergaard, O. (1988) Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage. J. Mol. Biol. 202, 333-342.
31. Champoux, J. J., and Aronoff, R. (1989) The effects of camptothecin on the reaction and the specificity of the wheat germ type I topoisomerase. J. Biol. Chem. 264, 1010-1015.
32. Hertzberg, R. P., Busby, R. W., Caranfa, M. J., Holden, K. G., Johnson, R. K., Hecht, S. M., and Kingsbury, W. D. (1990) Irreversible trapping of the DNA - topoisomerase I covalent complex. Affinity labeling of the camptothecin binding site. J. Biol. Chem. 265, 19287-19295.
33. Hsiang, Y.-H., Lihou, M. G., and Liu, L. F. (1989) Mechanism of cell killing by camptothecin: arrest of replication forks by drug-stabilized topoisomerase I - DNA cleavable complexes Cancer Res. 49, 5077-5082.
34. Tewey, K. M., Rowe, T. C., Chen, G. L., Yang, L., Halligan, B. D., and Liu, L. F. (1984) Adriamycin-induced DNA damage-mediated by mammalian DNA topoisomerase II. Science 226, 466-468.
35. Nelson, E. M., Tewey, K. M., and Liu, L. F. (1984) Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9-acridinylamino)methanesulfon-m-anisidide. Proc. Natl. Acad. Sci. U.S.A. 81, 1361-1365.
36. Waring, M. J. (1981) DNA modification and cancer. Annu. Rev. Biochem. 50, 159-192.
37. Been, M. D., Burgess, R. R., and Champoux, J. J. (1984) Nucleotide sequence preference at rat liver and wheat germ type 1 DNA topoisomerase breakage sites in duplex SV40 DNA. Nucleic Acids Res. 12, 3097-3114.
38. Bonven, B. J., Gocke, E., and Westergaard, O. (1985) A high affinity topoisomerase I binding sequence is clustered at DNase I hypersensitive sites in tetrahymena R-chromatin. Cell 41, 541-551.
39. Stevnsner, T., Mortensen, U. H., Westergaard, O., and Bonven, B. J. (1989) Interactions between eukaryotic DNA topoisomerase I and a specific binding sequence. J. Biol. Chem. 264, 10110-10113.
40. Jaxel, C., Capranico, G., Kerrigan, D., Kohn, K. W., and Pommier, Y. (1991) Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin. J. Biol. Chem 266, 20418-20423.
41. Fang, S. D., Wang, L.-K., and Hecht, S. M. (1993) Inhibitors of DNA topoisomerase I isolated from the roots of Zanthoxylum nitidum. J Org. Chem. 58, 5025-5027.
42. Janin, Y. L , Croisy, A., Riou, J.-F., and Bisagni, E. (1993) Synthesis and evaluation of new 6-amino-substituted benzo[c]-phenanthridine derivatives. J. Med. Chem. 36, 3686-3692.
43. Larsen, A K., Grondard, L., Couprie, J., Desoize, B., Comoe, L., Jardillier, J.-C., and Riou, J.-F. (1993) The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II. Biochem. Pharmacol. 46, 1403-1412.
44. Chen, G. L., Yang, L., Rowe, T. C., Halligan, B. D., Tewey, K. M., and Liu, L. F. (1984) Nonintercalative antitumor drugs interfere with the breakage - reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem. 259, 13560-13566.
45. Ross, W., Rowe, T., Glisson, B., Yaiowich, J , and Liu, L. (1984) Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res. 44, 5837-5860.
46. Tewey, K. M., Chen, G. L , Nelson, E. M., and Liu, L. F. (1984) Intercalative antitumor drugs interfere with the breakage - reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem. 259, 9182-9187.
47. Giovanella, B. C., Stehlin, J. S., Wall, M. E., Wani, M. C., Nicholas, A. W., Liu, L. F., Silber, R., and Potmesil, M. (1989) DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts. Science 246, 1046-1048.
48. Hertzberg, R. P., Caranfa, M. J., Holden, K. G., Jakas, D. R., Gallagher, G., Mattern, M. R., Mong, S. M., O'Leary-Bartus, J., Johnson, R. K., and Kingsbury, W. D. (1989) Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity. J. Med. Chem. 32, 715-720.
49. Ohno, R., Okada, K., Masaoka, T., Kuramoto, A., Arima, T., Yoshida, Y., Ariyoshi, H., Ichimaru, M., Sakai, Y., Oguro, M., Ito, Y., Morishima, Y., Yokomaku, S., and Ota, K. (1990) An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma. J. Clin. Oncol. 8, 1907-1912.
50. Kingsbury, W. D., Boehm, J. D., Jakas, D. R., Holden, K. G., Hecht, S. M., Gallagher, G., Caranfa, M. J., McCabe, F. L., Faucette, L. F., Johnson, R. K., and Hertzberg, R. P. (1991) Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity. J. Med. Chem. 34, 98-107.
51. Potmesil, M., and Pinedo, H , Eds (1995) Camptothecins: New Anticancer Agents, CRC Press, Boca Raton.
52. Eng, W.-K., Faucette, L., Johnson, R. K., and Sternglanz, R. (1988) Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptotheein. Mol. Pharmacol. 34, 755-760.
53. Beerman, T. A., McHugh, M. M., Sigmund, R. D., Lown, J. W., Rao, K. E., and Bathini, Y. (1992) Effects of analogs of the DNA minor groove binder Hoechst 33258 on topoisomerase II and I mediated activities. Biochim. Biophys Acta 1131, 53-61.
54. Chen, A. Y , Yu, C., Bodley, A., Peng, L. F., and Liu, L. F. (1993) A new mammalian DNA topoisomerase I poison Hoechst 33342: cytotoxicity and drug resistance in human cell cultures. Cancer Res. 53, 1332-1337.
55. Chen, A. Y., Yu, C., Gatto, B., and Liu, L. F. (1993) DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. Proc. Natl. Acad. Sci. U.S.A. 90, 8131-8135.
56. Fujii, N., Yamashita, Y., Chiba, S., Uosaki, Y., Saitoh, Y., Tuji, Y., and Nakano, H. (1993) UCE6, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from actinomycetes. J. Antibiot. 46, 1173-1174.
57. Fujii, N., Yamashita, Y., Saitoh, Y., and Nakano, H. (1993) Induction of mammalian DNA topoisomerase I-mediated DNA cleavage and DNA winding by bulgarein. J. Biol. Chem. 268, 13160-13165.
58. Fujii, N., Yamashita, Y., Ando, K., Agatsuma, T., Saitoh, Y., Gomi, K., Nishiie, K., and Nakano, H. (1994) UCE1022, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from Paecilomyces. J. Antibiot. 47, 949-951.
59. Li, C. J., Averbouk, L., and Pardee, A. B. (1993) Beta-lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin. J. Biol. Chem. 268, 22463-22468.
60. Yoshinari, T., Yamada, A., Uemura, D., Nomura, K., Arakawa, H., Kojiri, K., Yoshida, E., Suda, H., and Okura, A. (1993) Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110. Cancer Res. 53, 490-494.
61. Zhao, J., and Benbow, R. M. (1993) An inhibitor of DNA topoisomerase I from Xenopus laevis ovaries. Biochemistry 32, 10622-10628.
62. Stermitz, F. R., Gillespie, J. P., Amoros, L. G., Romero, R., Stermitz, T. A., Larson, K. A., Earl, S., and Ogg, J. E. (1975) Synthesis and biological activity of some antitumor benzophenanthridinium salts. J Med. Chem. 18, 708-713.
63. Zee-Cheng, R. K.-Y., and Cheng, C. C. (1975) Preparation and antileukemic activity of some alkoxybenzo[e]phenathridinium salts and corresponding dihydro derivatives. J. Med Chem. 18, 66-71.
64. Caolo, M. A., and Stermitz, F. R. (1979) Benzophenanthridinium salt equilibria. Heterocycles 12, 11-15.
65. Phillips, S. D., and Castle, R. N. (1981) A review of the chemistry of the antitumor benzo[c]phenanthridine alkaloids nitidine and fagaronine and of the related antitumor alkaloid coralyne. J. Heterocycl. Chem. 18, 223-232.
66. Cushman, M., and Mohan, P. (1985) Synthesis and antitumor activity of structural analogues of the anticancer benzophenanthridine alkaloid fagaronine chloride. J. Med. Chem. 28, 1031-1036.
67. Ishii, H., Chen, I. S., and Ishikawa, T. (1987) Studies on the chemical constituents of rutaceous plants. Part 62. Efficient synthesis of fagaronine, a phenolic benzo[c]phenanthridine alkaloid with antileukaemic activity. J. Chem. Soc., Perkin Trans. 1, 671-676.
68. Edwards, K. A., Halligan, B. D., Davis, J. L., Nivera, N. I., and Liu, L. F. (1982) Recognition sites of eukaryotic DNA topoisomerase I: DNA nucleotide sequencing analysis of topo I cleavage sites on SV40 DNA. Nucleic Acids Res. 10, 2565-2576.
69. Porter, S. E., and Champoux, J. J. (1988) Mapping in vivo topoisomerase I sites on simian virus 40 DNA: asymmetric distribution of sites on replicating molecules. Mol. Cell. Biol. 9, 541-550.
70. Pommier, Y., Capranico, G., Orr, A., and Kohn, K. A. (1991) Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide. Nucleic Acids Res. 19, 5973-5980.